Medeon Biodesign (ROCO:6499) Change In Inventory: NT$-3.8 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6499 Medeon Biodesign Inc ROCO:6499
69 GF Score
Price NT$71.50
GF Value NT$96.55
Valuation Modestly Undervalued
! 3 Warning Signs
View Full Analysis

What is Medeon Biodesign Change In Inventory?

Medeon Biodesign ROCO:6499 +9.33% 69 Change In Inventory is NT$-3.8 Mil as of Jun. 2026. GuruFocus rates ROCO:6499 with a GF Score™ of 69/100 and a GF Value™ of NT$96.55 (Modestly Undervalued). The stock has 3 warning signs investors should review.

Medeon Biodesign's change in inventory for the quarter that ended in Jun. 2026 was NT$-2.0 Mil. It means Medeon Biodesign's inventory increased by NT$2.0 Mil from Mar. 2026 to Jun. 2026 .

Medeon Biodesign's change in inventory for the fiscal year that ended in Dec. 2025 was NT$9.3 Mil. It means Medeon Biodesign's inventory declined by NT$9.3 Mil from Dec. 2024 to Dec. 2025 .

Medeon Biodesign's Total Inventories for the quarter that ended in Jun. 2026 was NT$30.0 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. Medeon Biodesign's Days Inventory for the quarter that ended in Jun. 2026 was 27.94.

Inventory Turnover measures how fast the company turns over its inventory within a year. Medeon Biodesign's Inventory Turnover for the quarter that ended in Jun. 2026 was 3.27.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. Medeon Biodesign's Inventory-to-Revenue for the quarter that ended in Jun. 2026 was 0.27.

Medeon Biodesign  (ROCO:6499) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Medeon Biodesign's Days Inventory for the quarter that ended in is calculated as:

Days Inventory=Average Total Inventories/Cost of Goods Sold*Days in Period
=29.009/94.744*365 / 4
=27.94

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Medeon Biodesign's Inventory Turnover for the quarter that ended in Jun. 2026 is calculated as

Inventory Turnover=Cost of Goods Sold / Average Total Inventories
=94.744 / 29.009
=3.27

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Medeon Biodesign's Inventory to Revenue for the quarter that ended in Jun. 2026 is calculated as

Inventory-to-Revenue=Average Total Inventories / Revenue
=29.009 / 106.612
=0.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medeon Biodesign Change In Inventory Related Terms

Medeon Biodesign Change In Inventory Historical Data

* Premium members only.

The historical data trend for Medeon Biodesign's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medeon Biodesign Change In Inventory Chart

Medeon Biodesign Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Change In Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only -10.04 -4.40 -0.71 -23.33 9.26

Medeon Biodesign Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Change In Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.18 0.71 0.63 -3.18 -1.99
ROCO:6499
69GF Score
Medeon Biodesign Inc ROCO:6499
Change In Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medeon Biodesign Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$-3.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Inventory →
What does a Change In Inventory of NT$-3.8 Mil mean?
Medeon Biodesign (ROCO:6499) has a Change In Inventory of NT$-3.8 Mil as of Jun. 2026. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Medeon Biodesign and its competitors.
Is Medeon Biodesign's Change In Inventory too high?
Medeon Biodesign's current Change In Inventory is NT$-3.8 Mil. Overall, Medeon Biodesign has a GF Score™ of 69/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medeon Biodesign's Change In Inventory compare to ISRG and BDX?
Medeon Biodesign's Change In Inventory of NT$-3.8 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Medical Devices & Instruments company?
A good Change In Inventory depends on the Medical Devices & Instruments industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for Medeon Biodesign and its competitors. Medeon Biodesign's current Change In Inventory is NT$-3.8 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medeon Biodesign stock overvalued right now?
Based on GuruFocus' analysis, Medeon Biodesign (ROCO:6499) is currently considered Modestly Undervalued. The stock's GF Value™ is NT$96.55, compared to a current price of NT$71.50 — trading 25.9% below its estimated fair value. The current Change In Inventory is NT$-3.8 Mil. Medeon Biodesign's overall GF Score™ is 69/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For Medeon Biodesign (ROCO:6499), the current Change In Inventory is NT$-3.8 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medeon Biodesign (ROCO:6499) Overvalued in 2026?

Based on GuruFocus' analysis, Medeon Biodesign stock appears to be undervalued. The current stock price of NT$71.50 is trading 25.9% below its estimated GF Value™ of NT$96.55. GuruFocus considers Medeon Biodesign to be Modestly Undervalued.

Key valuation signals for ROCO:6499:

  • Change In Inventory: NT$-3.8 Mil
  • GF Value™: NT$96.55 vs. price of NT$71.50 (25.9% below fair value)
  • GF Score™: 69/100 with 3 warning signs

No single metric tells the full story. See the ROCO:6499 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Medeon Biodesign Business Description

Address No. 116, HouGang Street, 7th Floor, Shilin District, Taipei, TWN, 11170
Medeon Biodesign Inc develops medical device products. The main services of the Group are the research and development of medical devices, manufacturing, and sale of injection molding and components of medical devices. The company provides products in the fields of cardiovascular and laparoscopic. Its business includes Medical Device Development Department and Medical Device Components Manufacturing and Sales Department. The majority of the company revenue comes from Medical Device Components Manufacturing and Sales Department segment. The company revenue is mainly derived from the USA.
69GF Score

Get the complete analysis for ROCO:6499

Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$71.50
Price
NT$96.55
GF Value